Diffusion Magnetic Resonance Imaging
"Diffusion Magnetic Resonance Imaging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diagnostic technique that incorporates the measurement of molecular diffusion (such as water or metabolites) for tissue assessment by MRI. The degree of molecular movement can be measured by changes of apparent diffusion coefficient (ADC) with time, as reflected by tissue microstructure. Diffusion MRI has been used to study BRAIN ISCHEMIA and tumor response to treatment.
|Diffusion Magnetic Resonance Imaging
- Diffusion Magnetic Resonance Imaging
- Magnetic Resonance Imaging, Diffusion
- Diffusion MRI
- Diffusion MRIs
- Diffusion Weighted MRI
- MRI, Diffusion Weighted
Below are MeSH descriptors whose meaning is more general than "Diffusion Magnetic Resonance Imaging".
Below are MeSH descriptors whose meaning is more specific than "Diffusion Magnetic Resonance Imaging".
This graph shows the total number of publications written about "Diffusion Magnetic Resonance Imaging" by people in this website by year, and whether "Diffusion Magnetic Resonance Imaging" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Diffusion Magnetic Resonance Imaging" by people in Profiles.
Safely reducing unnecessary benign breast biopsies by applying non-mass and DWI directional variance filters to ADC thresholding. BMC Med Imaging. 2022 09 29; 22(1):171.
Directional and inter-acquisition variability in diffusion-weighted imaging and editing for restricted diffusion. Magn Reson Med. 2022 11; 88(5):2298-2310.
Physically implausible signals as a quantitative quality assessment metric in prostate diffusion-weighted MR imaging. Abdom Radiol (NY). 2022 07; 47(7):2500-2508.
Efficacy and safety of an orally administered DGAT2 inhibitor alone or coadministered with a liver-targeted ACC inhibitor in adults with non-alcoholic steatohepatitis (NASH): rationale and design of the phase II, dose-ranging, dose-finding, randomised, placebo-controlled MIRNA (Metabolic Interventions to Resolve NASH with fibrosis) study. BMJ Open. 2022 03 30; 12(3):e056159.
Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI. Radiology. 2022 06; 303(3):588-589.
Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness. J Magn Reson Imaging. 2022 06; 55(6):1745-1758.
Can Pre-treatment Quantitative Multi-parametric MRI Predict the Outcome of Radiotherapy in Patients with Prostate Cancer? Acad Radiol. 2022 07; 29(7):977-985.
Development of a standardized MRI protocol for pancreas assessment in humans. PLoS One. 2021; 16(8):e0256029.
Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study. Acta Radiol. 2022 Jul; 63(7):877-888.
Intracranial atherosclerotic disease mechanistic subtypes drive hypoperfusion patterns. J Neuroimaging. 2021 07; 31(4):686-690.